Sanofi Consumer Healthcare India Ltd vs Sunrest Lifescience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Sanofi Consumer Healthcare India Ltd is ₹ 4592 as of 05 May 15:30 . The p/e ratio of Sanofi Consumer Healthcare India Ltd changed from 62.6 to 0 over 6 quarters. This represents a CAGR of -100.00% The p/e ratio of Sunrest Lifescience Ltd changed from 115.2 to 11.5 over 2 quarters. This represents a CAGR of -99.00% The market cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 11347 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of -100.00% The market cap of Sunrest Lifescience Ltd changed from ₹ 26.2 crore to ₹ 23.07 crore over 2 quarters. This represents a CAGR of -22.47% The revenue of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 234.8 crore as compare to the Dec '25 revenue of ₹ 255.6 crore. This represent the decline of -8.14% The revenue of Sunrest Lifescience Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 94.4 crore as compare to the Dec '25 ebitda of ₹ 94.4 crore. This represent the decline of 0% The ebitda of Sunrest Lifescience Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 62.7 crore to ₹ 67.8 crore over 7 quarters. This represents a CAGR of 4.57% The net profit of Sunrest Lifescience Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % to 0 % over 7 quarters. This represents a CAGR of -100.00% The dividend payout of Sunrest Lifescience Ltd changed from 0 % to 0 % over 7 quarters. This represents a CAGR of 0.0% .

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

About Sunrest Lifescience Ltd

Sunrest Lifescience Limited was originally incorporated as 'Sunrest Lifescience Private Limited' as a Private Company vide Certificate of Incorporation dated October 30, 2017, with the Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Sunrest Lifescience Limited' on March 21, 2023. The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market.
The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan.
It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste.
Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.

FAQs for the comparison of Sanofi Consumer Healthcare India Ltd and Sunrest Lifescience Ltd

Which company has a larger market capitalization, Sanofi Consumer Healthcare India Ltd or Sunrest Lifescience Ltd?

Market cap of Sanofi Consumer Healthcare India Ltd is 10,577 Cr while Market cap of Sunrest Lifescience Ltd is 30 Cr

What are the key factors driving the stock performance of Sanofi Consumer Healthcare India Ltd and Sunrest Lifescience Ltd?

The stock performance of Sanofi Consumer Healthcare India Ltd and Sunrest Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi Consumer Healthcare India Ltd and Sunrest Lifescience Ltd?

As of May 5, 2026, the Sanofi Consumer Healthcare India Ltd stock price is INR ₹4592.6. On the other hand, Sunrest Lifescience Ltd stock price is INR ₹36.0.

How do dividend payouts of Sanofi Consumer Healthcare India Ltd and Sunrest Lifescience Ltd compare?

To compare the dividend payouts of Sanofi Consumer Healthcare India Ltd and Sunrest Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.